NUAK1, one of the AMP-activated protein kinase (AMPK)-related kinases [59], was reported to play an important role in regulating tau levels, indicating that NUAK1 to be a novel therapeutic entry point for tauopathies [60]. This evidence concerns the gene MAPT and tauopathy.